Injectafer Approval Expanded to Pediatric Patients With Iron Deficiency Anemia
The Food and Drug Administration (FDA) has expanded the approval of Injectafer® (ferric carboxymaltose injection) to include patients 1 year of age and older with iron deficiency anemia (IDA) who have either intolerance to oral…